PL373593A1 - Zawierająca androgeny kompozycja farmaceutyczna isposób leczenia depresji - Google Patents
Zawierająca androgeny kompozycja farmaceutyczna isposób leczenia depresjiInfo
- Publication number
- PL373593A1 PL373593A1 PL03373593A PL37359303A PL373593A1 PL 373593 A1 PL373593 A1 PL 373593A1 PL 03373593 A PL03373593 A PL 03373593A PL 37359303 A PL37359303 A PL 37359303A PL 373593 A1 PL373593 A1 PL 373593A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- treating depression
- androgen
- androgen pharmaceutical
- depression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/098,232 US20040002482A1 (en) | 2000-08-30 | 2002-03-15 | Androgen pharmaceutical composition and method for treating depression |
US10/153,468 US20040092494A9 (en) | 2000-08-30 | 2002-05-21 | Method of increasing testosterone and related steroid concentrations in women |
Publications (1)
Publication Number | Publication Date |
---|---|
PL373593A1 true PL373593A1 (pl) | 2005-09-05 |
Family
ID=33302446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03373593A PL373593A1 (pl) | 2002-03-15 | 2003-03-14 | Zawierająca androgeny kompozycja farmaceutyczna isposób leczenia depresji |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1511494B1 (pl) |
KR (1) | KR20050074896A (pl) |
CN (1) | CN100544725C (pl) |
AU (1) | AU2003228314C1 (pl) |
CA (1) | CA2484164C (pl) |
HU (1) | HU230920B1 (pl) |
MA (1) | MA27690A1 (pl) |
MX (1) | MXPA04008988A (pl) |
PL (1) | PL373593A1 (pl) |
WO (1) | WO2004091631A1 (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
MY139721A (en) | 2002-04-19 | 2009-10-30 | Cpex Pharmaceuticals Inc | Pharmaceutical composition |
US8883769B2 (en) | 2003-06-18 | 2014-11-11 | White Mountain Pharma, Inc. | Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
US20040259852A1 (en) | 2003-06-18 | 2004-12-23 | White Hillary D. | Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome |
AU2006254742C1 (en) * | 2005-06-03 | 2011-11-03 | Acrux Dds Pty Ltd | Method and composition for transdermal drug delivery |
ZA200711040B (en) | 2005-06-03 | 2009-04-29 | Acrux Dds Pty Ltd | Method and composition for transdermal drug delivery |
WO2006128255A1 (en) * | 2005-06-03 | 2006-12-07 | Acrux Dds Pty Ltd | Method and composition for transdermal drug delivery |
US10080760B2 (en) * | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
EP2640398A4 (en) | 2010-11-18 | 2014-05-14 | White Mountain Pharma Inc | METHODS FOR TREATING CHRONIC OR REFRACTORY PAIN AND / OR INCREASING PAIN THRESHOLD IN A SUBJECT, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698589A (en) * | 1993-06-01 | 1997-12-16 | International Medical Innovations, Inc. | Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
WO1998034621A1 (en) * | 1997-02-07 | 1998-08-13 | Theratech, Inc. | Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency |
JP4139860B2 (ja) * | 1997-11-10 | 2008-08-27 | ストラカン インターナショナル リミティッド | 浸透増強および刺激減少システム |
US5880117A (en) * | 1998-07-13 | 1999-03-09 | Arnold; Patrick | Use of 4-androstenediol to increase testosterone levels in humans |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
PL360992A1 (pl) * | 2000-08-30 | 2004-09-20 | Unimed Pharmaceuticals,Inc. | Sposób zwiększania stężenia testosteronu i pokrewnego sterydu u kobiet |
-
2003
- 2003-03-14 WO PCT/US2003/007910 patent/WO2004091631A1/en active Application Filing
- 2003-03-14 CA CA002484164A patent/CA2484164C/en not_active Expired - Lifetime
- 2003-03-14 MX MXPA04008988A patent/MXPA04008988A/es active IP Right Grant
- 2003-03-14 AU AU2003228314A patent/AU2003228314C1/en not_active Expired
- 2003-03-14 CN CNB038102811A patent/CN100544725C/zh not_active Expired - Lifetime
- 2003-03-14 PL PL03373593A patent/PL373593A1/pl unknown
- 2003-03-14 KR KR1020047014500A patent/KR20050074896A/ko active Search and Examination
- 2003-03-14 HU HU0600855A patent/HU230920B1/hu unknown
- 2003-03-14 EP EP03726062.7A patent/EP1511494B1/en not_active Expired - Lifetime
-
2004
- 2004-09-14 MA MA27858A patent/MA27690A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2484164A1 (en) | 2004-10-28 |
AU2003228314B8 (en) | 2008-04-24 |
MXPA04008988A (es) | 2006-05-25 |
EP1511494A4 (en) | 2010-10-06 |
WO2004091631A1 (en) | 2004-10-28 |
HUP0600855A2 (en) | 2007-02-28 |
AU2003228314A1 (en) | 2004-11-04 |
CA2484164C (en) | 2009-12-29 |
MA27690A1 (fr) | 2006-01-02 |
EP1511494B1 (en) | 2020-08-19 |
HU230920B1 (hu) | 2019-03-28 |
CN100544725C (zh) | 2009-09-30 |
AU2003228314C1 (en) | 2009-03-26 |
KR20050074896A (ko) | 2005-07-19 |
AU2003228314B2 (en) | 2008-04-10 |
CN1652793A (zh) | 2005-08-10 |
HUP0600855A3 (en) | 2012-09-28 |
EP1511494A1 (en) | 2005-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0229071D0 (en) | Cosmetic method and composition for enhancing attractiveness | |
AU2002329022A1 (en) | Method and pharmaceutical composition for treating inflammation | |
GB0110288D0 (en) | Composition and treatment method | |
IL164219A0 (en) | Method for treating and preventing hyparathyroidism | |
EP1468118A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
AU2003268032A8 (en) | Composition and methods for treatment and screening | |
AUPS236902A0 (en) | Composition and method for treating hypertension | |
AU2003232044A8 (en) | Composition and method for dermatological treatment | |
AU2003219747A8 (en) | Composition and method for coating medical devices | |
IL161073A0 (en) | Composition and method for treating diabetes | |
IL163981A0 (en) | Androgen pharmaceutical composition and method fortreating depression | |
PL373593A1 (pl) | Zawierająca androgeny kompozycja farmaceutyczna isposób leczenia depresji | |
AU2003213048A8 (en) | Composition and method for protecting labile active components | |
AU2003262840A1 (en) | Composition and method for treating skin | |
EP1545554A4 (en) | METHOD AND COMPOSITIONS FOR TREATING DIABETES MELLITUS | |
AU2003259202A8 (en) | Compositions and methods for treating and preventing infection | |
AU2003295574A8 (en) | Method and compositions for temporarily incapaciting subjets | |
AU2003275433A8 (en) | Compositions and methods for treating pain | |
AU2003210474A8 (en) | Composition and method for inhibiting hypersensitivity | |
AU2003278935A8 (en) | Method and composition for treating neurodegenerative disorders | |
IL163878A0 (en) | Compositions and methods for treating mdma-inducedtoxicity | |
GB0203528D0 (en) | Process and composition | |
EP1539084A4 (en) | COMPOSITION AND METHODS FOR TREATING SOFT NAILS | |
PL377357A1 (pl) | Sposób i kompozycja do leczenia lęku | |
GB0210747D0 (en) | Composition and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |